Cochlear Ltd
ASX:COH
Cochlear Ltd
ASX:COH
Price:
320.82 AUD
1.43%
Market Closed
Updated:
May 5, 2024
Cochlear Ltd
Operating Income
|
Cochlear Ltd
Operating Income Peer Comparison
Comparables:
NTI
IPD
C
CYC
OIL
EMV
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Cochlear Ltd
ASX:COH
|
Operating Income
AU$491.1m
|
CAGR 3-Years
36%
|
CAGR 5-Years
6%
|
CAGR 10-Years
15%
|
|
|
Neurotech International Ltd
ASX:NTI
|
Operating Income
-AU$7.8m
|
CAGR 3-Years
-82%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
ImpediMed Ltd
ASX:IPD
|
Operating Income
-AU$20.7m
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-12%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Operating Income
-AU$8.6m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-119%
|
CAGR 10-Years
-25%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Operating Income
-AU$5.7m
|
CAGR 3-Years
-66%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-11%
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Operating Income
-AU$3.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
N/A
|
See Also
What is Cochlear Ltd's Operating Income?
Operating Income
491.1m
AUD
491.1m
AUD
Based on the financial report for Dec 31, 2023, Cochlear Ltd's Operating Income amounts to 491.1m AUD.
What is Cochlear Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
15%
15%
Over the last year, the Operating Income growth was 34%. The average annual Operating Income growth rates for Cochlear Ltd have been 36% over the past three years , 6% over the past five years , and 15% over the past ten years .
You don't have any saved screeners yet
